학술논문
Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Effect of a One-Year Consolidation Treatment with Ponatinib 15 Mg on Treatment Free-Remission Rate in Patients with Philadelphia-Positive Chronic Myeloid Leukemia, Who Had Previously Achieved a Deep Molecular Response with Imatinib (PonaZero_study)
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:5904-5904
Subject
Language
ISSN
0006-4971